Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left" rowspan="2">lncRNA</td><td align="center" rowspan="2">Healthy control</td><td align="center" colspan="2">HCC</td></tr><tr class="thead"><td align="center">HBV (−)</td><td align="center">HBV (+)</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">HULC</td><td align="center">2/20 (10%)</td><td align="center">3/12 (25%)</td><td align="center">16/18 (90%)</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

HULC in the plasma of healthy controls and HCC patients with different HBV status.

BioMed Research International

tab3

Table 3

Table 3: Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma 